National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$43.00
add to cart

Rights & Permissions

topleft topright

Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health (2006)
Board on Science, Technology, and Economic Policy (STEP)

Citation Manager

. "4 Trends in the Patenting and Licensing of Genomic and Protein Inventions and Their Impact on Biomedical Research." Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health. Washington, DC: The National Academies Press, 2006.

Please select a format:

BibTeX EndNote RefMan


Page
130
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health

TABLE 4-5 Average Number of Adverse Effects from Not Receiving Research Inputs, Academic Respondents by Research Goal and for Pathways and Industry Respondents

 

Random Sample

Research Goal

Pathways

Industry

Drug Discovery

Basic Research

Other

CTLA4

EGF

NF-kB

Academic Supplier

Delay >1 month

0.68

0.98

0.69

0.33

0.83

1.2

2.85

0.78

Change Research Approach

0.56

0.89

0.54

0.3

0.45

0.7

2.24

0.68

Abandon

0.22

0.07

0.24

0.21

0.27

0.2

0.62

0.39

Make In-house

0.67

0.88

0.65

0.59

0.93

1.2

2.29

1.01

Industry Supplier

Delay >1 month

0.4

0.75

0.39

0.18

1.02

1.1

0.87

0.35

Change Research Approach

0.46

0.66

0.42

0.56

0.68

0.7

1.66

0.49

Abandon

0.27

0.08

0.3

0.26

0.58

0.9

0.28

0.32

Make In-house

0.31

0.44

0.28

0.47

0.69

0.8

0.71

0.33

Respondents

242

24

195

23

21

24

26

62

 

SOURCE: Walsh et al., 2005.

Page
130